跳至主要内容
临床试验/IRCT20190615043900N1
IRCT20190615043900N1已完成未知

Effectiveness of acupuncture treatment on chemotherapy induced peripheral neuropathy: a pilot randomized controlled trial

Beijing University of Chinese Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Patients with age between 18 and 70 years
  • Who have received neurotoxic chemotherapy (at least one complete course)
  • Have experienced symptoms of chemotherapy-induced peripheral neuropathy for more than three months
  • Have scores = 4 on 10 on the Numerical Rating Scale (NRS)
  • Accept and sign an informed consent form
  • Patients were also not to use medications such as Tricyclic antidepressants (TCA), calcium channel blockers, and membrane stabilizing drugs for the prevention or treatment of the neuropathy for at least one month before enrollment

排除标准

  • History of disease that causes neuropathy, such as diabetes, multiple sclerosis, HIV, and Parkinson
  • The presence of peripheral neuropathy or history of peripheral neuropathy due to any cause excluding chemotherapy
  • Alcohol abuse
  • Psychological disease
  • Severe dysfunction of the heart, kidneys, or liver

研究者

发起方
Beijing University of Chinese Medicine

相似试验